Stratos Wealth Partners LTD. Has $8.38 Million Stock Position in UnitedHealth Group Incorporated $UNH

Stratos Wealth Partners LTD. increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 77.3% during the second quarter, Holdings Channel reports. The institutional investor owned 26,871 shares of the healthcare conglomerate’s stock after purchasing an additional 11,717 shares during the period. Stratos Wealth Partners LTD.’s holdings in UnitedHealth Group were worth $8,383,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Nabity Jensen Investment Management Inc increased its holdings in UnitedHealth Group by 0.9% during the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock worth $1,446,000 after purchasing an additional 24 shares in the last quarter. Atlantic Edge Private Wealth Management LLC increased its holdings in UnitedHealth Group by 8.9% during the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock worth $160,000 after purchasing an additional 25 shares in the last quarter. Osborne Partners Capital Management LLC increased its holdings in UnitedHealth Group by 2.5% during the 1st quarter. Osborne Partners Capital Management LLC now owns 1,066 shares of the healthcare conglomerate’s stock worth $558,000 after purchasing an additional 26 shares in the last quarter. HHM Wealth Advisors LLC increased its holdings in UnitedHealth Group by 0.9% during the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock worth $1,544,000 after purchasing an additional 26 shares in the last quarter. Finally, MPS Loria Financial Planners LLC grew its holdings in shares of UnitedHealth Group by 0.4% in the first quarter. MPS Loria Financial Planners LLC now owns 7,256 shares of the healthcare conglomerate’s stock valued at $3,800,000 after acquiring an additional 27 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 0.0%

NYSE:UNH opened at $356.53 on Friday. The company has a market cap of $322.90 billion, a P/E ratio of 15.45, a P/E/G ratio of 2.31 and a beta of 0.47. The stock’s fifty day moving average price is $329.38 and its two-hundred day moving average price is $344.86. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Analysts Set New Price Targets

Several research firms have recently issued reports on UNH. Mizuho upped their target price on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Wells Fargo & Company upped their target price on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Piper Sandler reduced their target price on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Zacks Research raised UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $385.13.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.